These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 10397022

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Acyl-coenzyme A: cholesterol acyltransferase (ACAT)].
    Miyazaki A, Watanabe T.
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():89-91. PubMed ID: 15658270
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Acyl-coenzyme A:cholesterol acyltransferase-2 (ACAT-2) is responsible for elevated intestinal ACAT activity in diabetic rats.
    Hori M, Satoh M, Furukawa K, Sakamoto Y, Hakamata H, Komohara Y, Takeya M, Sasaki Y, Miyazaki A, Horiuchi S.
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1689-95. PubMed ID: 15242859
    [Abstract] [Full Text] [Related]

  • 7. Cholesterol esters and atherosclerosis-a game of ACAT and mouse.
    Rudel LL, Shelness GS.
    Nat Med; 2000 Dec; 6(12):1313-4. PubMed ID: 11100106
    [No Abstract] [Full Text] [Related]

  • 8. Roles of acyl-coenzyme A:cholesterol acyltransferase-1 and -2.
    Chang TY, Chang CC, Lin S, Yu C, Li BL, Miyazaki A.
    Curr Opin Lipidol; 2001 Jun; 12(3):289-96. PubMed ID: 11353332
    [Abstract] [Full Text] [Related]

  • 9. Acyl-coenzyme A:cholesterol acyltransferase inhibitors for controlling hypercholesterolemia and atherosclerosis.
    Miyazaki A, Sakai M, Sakamoto Y, Horiuchi S.
    Curr Opin Investig Drugs; 2003 Sep; 4(9):1095-9. PubMed ID: 14582454
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Selectivity of pyripyropene derivatives in inhibition toward acyl-CoA:cholesterol acyltransferase 2 isozyme.
    Ohshiro T, Ohte S, Matsuda D, Ohtawa M, Nagamitsu T, Sunazuka T, Harigaya Y, Rudel LL, Omura S, Tomoda H.
    J Antibiot (Tokyo); 2008 Aug; 61(8):503-8. PubMed ID: 18997389
    [Abstract] [Full Text] [Related]

  • 13. Tamoxifen is a potent inhibitor of cholesterol esterification and prevents the formation of foam cells.
    de Medina P, Payré BL, Bernad J, Bosser I, Pipy B, Silvente-Poirot S, Favre G, Faye JC, Poirot M.
    J Pharmacol Exp Ther; 2004 Mar; 308(3):1165-73. PubMed ID: 14617686
    [Abstract] [Full Text] [Related]

  • 14. Cholesteryl ester metabolism in atherosclerotic arterial tissue.
    St Clair RW.
    Ann N Y Acad Sci; 1976 Mar; 275():228-37. PubMed ID: 1070273
    [No Abstract] [Full Text] [Related]

  • 15. Enhancement of human ACAT1 gene expression to promote the macrophage-derived foam cell formation by dexamethasone.
    Yang L, Yang JB, Chen J, Yu GY, Zhou P, Lei L, Wang ZZ, Cy Chang C, Yang XY, Chang TY, Li BL.
    Cell Res; 2004 Aug; 14(4):315-23. PubMed ID: 15353128
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Glibenclamide acts as an inhibitor of acyl-CoA:cholesterol acyltransferase enzyme.
    Ohgami N, Kuniyasu A, Furukawa K, Miyazaki A, Hakamata H, Horiuchi S, Nakayama H.
    Biochem Biophys Res Commun; 2000 Oct 22; 277(2):417-22. PubMed ID: 11032738
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Acyl-coenzyme A:cholesterol acyltransferase.
    Chang TY, Chang CC, Cheng D.
    Annu Rev Biochem; 1997 Oct 22; 66():613-38. PubMed ID: 9242919
    [Abstract] [Full Text] [Related]

  • 20. Apoptosis and plaque destabilization in atherosclerosis: the role of macrophage apoptosis induced by cholesterol.
    Tabas I.
    Cell Death Differ; 2004 Jul 22; 11 Suppl 1():S12-6. PubMed ID: 15143347
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.